Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Titomic is an Australian additive manufacturing company specializing in large-scale metal 3D printing using its proprietary Titomic Kinetic Fusion (TKF) technology. While serving diverse sectors such as defense and aerospace, the company maintains a significant healthcare presence through its production of high-performance, biocompatible titanium medical implants. Their cold-spray process allows for the creation of complex, porous structures that facilitate superior osseointegration, making them ideal for orthopedic, spinal, and dental applications. Titomic's technology enables the rapid manufacturing of customized prosthetic devices that can be tailored to individual patient anatomy. Headquartered in Melbourne and listed on the Australian Securities Exchange, the company operates globally with facilities in Europe and the United States.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Titomic.